Safety and Pharmacokinetics of 566C80, a Hydroxynaphthoquinone with Anti-Pneumocystis carinii Activity: A Phase I Study in Human Immunodeficiency Virus (HIV)-Infected Men
Walter T. Hughes(St. Jude Children's Research Hospital), Mandy Rogers(St. Jude Children's Research Hospital), Seth Hetherington(Unknown), Sam Liao, Glenda H. Fullen(St. Jude Children's Research Hospital), Stephen B. Palte(St. Jude Children's Research Hospital), David P. Rosenbaum(Ardelyx (United States)), Wren Kennedy(St. Jude Children's Research Hospital), Daniel S. Stein(St. Jude Children's Research Hospital), Danny J. Lancaster(Houston Methodist), Patricia M. Flynn(St. Jude Children's Research Hospital), Jerry L. Shenep(St. Jude Children's Research Hospital), Martin Blum(University of Hohenheim)
Cited by 74
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
|New England Journal of Medicine|2016|348